Abstract
Non-covalent recognition of ubiquitin (Ub) and ubiquitin-like molecules (Ubls) by interacting proteins has an important role in the regulation of protein function and initiation of signalling events. In addition, growing evidence suggests that regulation of p53 subcellular localization contributes to the biological outcome of the p53 response. Cytoplasmic p53 is shown to promote apoptosis and inhibit the induction of autophagy. In this study we show that NEDD8 ultimate buster 1 (NUB1), a non-covalent interactor of the Ubl NEDD8 (neural precursor cell expressed, developmentally downregulated 8), controls the localization of p53. Expression of NUB1 leads to decreased modification of p53 with NEDD8 and stimulation of p53 ubiquitination. The biological outcome is the cytoplasmic localization and inhibition of the transcriptional activity of p53. Although the effects of NUB1 on p53 depend on NEDDylation and the murine double minute 2 (Mdm2) E3-ligase, the cooperation of NEDD8 with ubiquitin is required. The data identify a role for NEDD8 in controlling p53 localization and suggest that NEDD8 can control protein function through its non-covalent recognition by interacting proteins.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Abida WM, Nikolaev A, Zhao W, Zhang W, Gu W . (2007). FBXO11 promotes the Neddylation of p53 and inhibits its transcriptional activity. J Biol Chem 282: 1797–1804.
Boyd SD, Tsai KY, Jacks T . (2000). An intact HDM2 RING-finger domain is required for nuclear exclusion of p53. Nat Cell Biol 2: 563–568.
Brooks CL, Gu W . (2006). p53 ubiquitination: Mdm2 and beyond. Mol Cell 21: 307–315.
Budanov AV, Karin M . (2008). p53 target genes sestrin1 and sestrin2 connect genotoxic stress and mTOR signaling. Cell 134: 451–460.
Carter S, Bischof O, Dejean A, Vousden KH . (2007). C-terminal modifications regulate MDM2 dissociation and nuclear export of p53. Nat Cell Biol 9: 428–435.
Carter S, Vousden KH . (2009). Modifications of p53: competing for the lysines. Curr Opin Genet Dev 19: 18–24.
Chipuk JE, Bouchier-Hayes L, Kuwana T, Newmeyer DD, Green DR . (2005). PUMA couples the nuclear and cytoplasmic proapoptotic function of p53. Science 309: 1732–1735.
Chipuk JE, Kuwana T, Bouchier-Hayes L, Droin NM, Newmeyer DD, Schuler M et al. (2004). Direct activation of Bax by p53 mediates mitochondrial membrane permeabilization and apoptosis. Science 303: 1010–1014.
Coutts AS, Adams CJ, La Thangue NB . (2009). p53 ubiquitination by Mdm2: a never ending tail? DNA Repair (Amst) 8: 483–490.
Crighton D, Wilkinson S, O'Prey J, Syed N, Smith P, Harrison PR et al. (2006). DRAM, a p53-induced modulator of autophagy, is critical for apoptosis. Cell 126: 121–134.
Dohmesen C, Koeppel M, Dobbelstein M . (2008). Specific inhibition of Mdm2-mediated neddylation by Tip60. Cell Cycle 7: 222–231.
Geyer RK, Yu ZK, Maki CG . (2000). The MDM2 RING-finger domain is required to promote p53 nuclear export. Nat Cell Biol 2: 569–573.
Green DR, Kroemer G . (2009). Cytoplasmic functions of the tumour suppressor p53. Nature 458: 1127–1130.
Hicke L, Schubert HL, Hill CP . (2005). Ubiquitin-binding domains. Nat Rev Mol Cell Biol 6: 610–621.
Hipp MS, Raasi S, Groettrup M, Schmidtke G . (2004). NEDD8 ultimate buster-1L interacts with the ubiquitin-like protein FAT10 and accelerates its degradation. J Biol Chem 279: 16503–16510.
Hurley JH, Lee S, Prag G . (2006). Ubiquitin-binding domains. Biochem J 399: 361–372.
Kamitani T, Kito K, Fukuda-Kamitani T, Yeh ET . (2001). Targeting of NEDD8 and its conjugates for proteasomal degradation by NUB1. J Biol Chem 276: 46655–46660.
Kerscher O, Felberbaum R, Hochstrasser M . (2006). Modification of proteins by ubiquitin and ubiquitin-like proteins. Annu Rev Cell Dev Biol 22: 159–180.
Kirkin V, Dikic I . (2007). Role of ubiquitin- and Ubl-binding proteins in cell signaling. Curr Opin Cell Biol 19: 199–205.
Kito K, Yeh ET, Kamitani T . (2001). NUB1, a NEDD8-interacting protein, is induced by interferon and down-regulates the NEDD8 expression. J Biol Chem 276: 20603–20609.
Laine A, Topisirovic I, Zhai D, Reed JC, Borden KL, Ronai Z . (2006). Regulation of p53 Localization and Activity by Ubc13. Mol Cell Biol 26: 8901–8913.
Lee JT, Gu W . (2010). The multiple levels of regulation by p53 ubiquitination. Cell Death Differ 17: 86–92.
Lee KAW, Zerivitz K, Akusjärvi G . (1994). Small-scale preparation of nuclear extracts from mammalian cells. In: JE Celis (ed). Cell Biology: A Laboratory Handbook vol. I. Academic Press (Elsevier): Oxford, UK, pp 668–673.
Leu JI, Dumont P, Hafey M, Murphy ME, George DL . (2004). Mitochondrial p53 activates Bak and causes disruption of a Bak-Mcl1 complex. Nat Cell Biol 6: 443–450.
Li M, Brooks CL, Wu-Baer F, Chen D, Baer R, Gu W . (2003). Mono- versus polyubiquitination: differential control of p53 fate by Mdm2. Science 302: 1972–1975.
Lohrum MA, Woods DB, Ludwig RL, Balint E, Vousden KH . (2001). C-terminal ubiquitination of p53 contributes to nuclear export. Mol Cell Biol 21: 8521–8532.
Maiuri MC, Malik SA, Morselli E, Kepp O, Criollo A, Mouchel PL et al. (2009). Stimulation of autophagy by the p53 target gene Sestrin2. Cell Cycle 8: 1571–1576.
Marchenko ND, Wolff S, Erster S, Becker K, Moll UM . (2007). Monoubiquitylation promotes mitochondrial p53 translocation. EMBO J 26: 923–934.
Mihara M, Erster S, Zaika A, Petrenko O, Chittenden T, Pancoska P et al. (2003). p53 has a direct apoptogenic role at the mitochondria. Mol Cell 11: 577–590.
Nikolaev AY, Li M, Puskas N, Qin J, Gu W . (2003). Parc: a cytoplasmic anchor for p53. Cell 10: 29–40.
Oh W, Lee EW, Sung YH, Yang MR, Ghim J, Lee HW et al. (2006). Jab1 induces the cytoplasmic localization and degradation of p53 in coordination with Hdm2. J Biol Chem 281: 17457–17465.
Rabut G, Peter M . (2008). Function and regulation of protein neddylation. ‘Protein modifications: beyond the usual suspects’ review series. EMBO Rep 9: 969–976.
Schmidtke G, Kalveram B, Weber E, Bochtler P, Lukasiak S, Hipp MS et al. (2006). The UBA domains of NUB1L are required for binding but not for accelerated degradation of the ubiquitin-like modifier FAT10. J Biol Chem 281: 20045–20054.
Speidel D, Helmbold H, Deppert W . (2006). Dissection of transcriptional and non-transcriptional p53 activities in the response to genotoxic stress. Oncogene 25: 940–953.
Sundqvist A, Liu G, Mirsaliotis A, Xirodimas DP . (2009). Regulation of nucleolar signalling to p53 through NEDDylation of L11. EMBO Rep 10: 1132–1139.
Tanji K, Tanaka T, Kamitani T . (2005). Interaction of NUB1 with the proteasome subunit S5a. Biochem Biophys Res Commun 337: 116–120.
Tasdemir E, Maiuri MC, Galluzzi L, Vitale I, Djavaheri-Mergny M, D'Amelio M et al. (2008). Regulation of autophagy by cytoplasmic p53. Nat Cell Biol 10: 676–687.
Tatham MH, Rodriguez MS, Xirodimas DP, Hay RT . (2009). Detection of protein SUMOylation in vivo. Nat Protoc 4: 1363–1371.
Vogelstein B, Lane D, Levine AJ . (2000). Surfing the p53 network. Nature 408: 307–310.
Welchman RL, Gordon C, Mayer RJ . (2005). Ubiquitin and ubiquitin-like proteins as multifunctional signals. Nat Rev Mol Cell Biol 6: 599–609.
Xirodimas D, Saville MK, Edling C, Lane DP, Lain S . (2001a). Different effects of p14ARF on the levels of ubiquitinated p53 and Mdm2 in vivo. Oncogene 20: 4972–4983.
Xirodimas DP . (2008). Novel substrates and functions for the ubiquitin-like molecule NEDD8. Biochem Soc Trans 36: 802–806.
Xirodimas DP, Saville MK, Bourdon JC, Hay RT, Lane DP . (2004). Mdm2-mediated NEDD8 conjugation of p53 inhibits its transcriptional activity. Cell 118: 83–97.
Xirodimas DP, Stephen CW, Lane DP . (2001b). Cocompartmentalization of p53 and Mdm2 is a major determinant for Mdm2-mediated degradation of p53. Exp Cell Res 270: 66–77.
Acknowledgements
We thank Drs Kamitani, Bourdon and Saville for reagents. We also thank Neil Hattersley for help with the immunofluorescence experiments. The work is supported by the Association for International Cancer Research (AICR). DPX is an AICR Research Fellow.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
Supplementary Information accompanies the paper on the Oncogene website
Supplementary information
Rights and permissions
About this article
Cite this article
Liu, G., Xirodimas, D. NUB1 promotes cytoplasmic localization of p53 through cooperation of the NEDD8 and ubiquitin pathways. Oncogene 29, 2252–2261 (2010). https://doi.org/10.1038/onc.2009.494
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/onc.2009.494
Keywords
This article is cited by
-
p53 regulation by ubiquitin and ubiquitin-like modifications
Genome Instability & Disease (2022)
-
Histone deacetylase 1 induced by neddylation inhibition contributes to drug resistance in acute myelogenous leukemia
Cell Communication and Signaling (2019)
-
NEDDylation promotes nuclear protein aggregation and protects the Ubiquitin Proteasome System upon proteotoxic stress
Nature Communications (2018)
-
The Nedd8 Non-covalent Binding Region in the Smurf HECT Domain is Critical to its Ubiquitn Ligase Function
Scientific Reports (2017)
-
The NEDD8 inhibitor MLN4924 increases the size of the nucleolus and activates p53 through the ribosomal-Mdm2 pathway
Oncogene (2016)